Format

Send to

Choose Destination
Semin Immunol. 2013 Apr;25(2):89-103. doi: 10.1016/j.smim.2013.04.007. Epub 2013 Jun 5.

Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Author information

1
Mayo Clinic Vaccine Research Group, Rochester, MN 55905, USA. Poland.gregory@mayo.edu

Abstract

Vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization, often based on novel data resulting from high throughput "omics" technologies. As a result of these technologies, 21st century vaccinology will increasingly see the abandonment of a "one size fits all" approach to vaccine dosing and delivery, as well as the abandonment of the empiric "isolate-inactivate-inject" paradigm for vaccine development. In this review, we discuss the immune response network theory and its application to the new field of vaccinomics and adversomics, and illustrate how vaccinomics can lead to new vaccine candidates, new understandings of how vaccines stimulate immune responses, new biomarkers for vaccine response, and facilitate the understanding of what genetic and other factors might be responsible for rare side effects due to vaccines. Perhaps most exciting will be the ability, at a systems biology level, to integrate increasingly complex high throughput data into descriptive and predictive equations for immune responses to vaccines. Herein, we discuss the above with a view toward the future of vaccinology.

KEYWORDS:

Adaptive immunity; Adversomics; Biotechnology; Computational biology; Genomics; Immune response network theory; Immunogenetics; Individualized medicine; Individualized vaccinology; Modeling; Predictive equation; Proteomics; Systems biology; Vaccination; Vaccines; Vaccinomics

PMID:
23755893
PMCID:
PMC3752773
DOI:
10.1016/j.smim.2013.04.007
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center